Skip to Content

American Cryostem Corp CRYO Stock Quote

| Rating as of

Morningstar‘s Stock Analysis CRYO

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics CRYO

Company Profile CRYO

Business Description

American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.

1 Meridian Road, Suite 5
Eatontown, NJ, 07724
T +1 732 747-1007
Industry Biotechnology
Most Recent Earnings Mar 31, 2022
Fiscal Year End Sep 30, 2022
Stock Type Slow Growth
Employees 6